Evidence map›Paper›PMID 36757553›Full record

ArticleEJNMMI research2023

Impact of framing scheme optimization and smoking status on binding potential analysis in dynamic PET with [

Cláudia Régio Brambilla, Jürgen Scheins, Lutz Tellmann, Ahlam Issa, Hans Herzog, N Jon Shah, Irene Neuner, Christoph W Lerche

Open access · goldAbstract read
In one paragraph

Article in EJNMMI research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Cláudia Régio BrambillaInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany. c.regio.brambilla@fz-juelich.de.ORCID http://orcid.org/0000-0002-3735-8511
Jürgen ScheinsInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.
Lutz TellmannInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.
Ahlam IssaInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.
Hans HerzogInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.
N Jon ShahInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.
Irene NeunerInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.
Christoph W LercheInstitute of Neuroscience and Medicine, INM-4, Forschungszentrum Jülich GmbH, Jülich, Germany.
Forschungszentrum Jülich · DE

Funding

Deutsche Forschungsgemeinschaft 491111487FP7 Health 602621
6 · The paper itself

Abstract

backgroundFor positron emission tomography (PET) ligands, such as [

resultsWhen applying F-tests to the 'Const 5 min' framing scheme, effect sizes (η

conclusionsBased on an [

Indexed as

Framing schememGluR5Non-displaceable binding potentialPETQuantification biasSchizophreniaSmoking status

Identifiers

PMID36757553
PMCPMC9911569
OpenAlexW4319656178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.